Daniella Kranjac
Investing Profile
AVANT BIO thesis
Our Approach A laser focus on the enabling technologies shaping how tomorrow’s therapeutics are developed. We Are Focused We See New Opportunities We Catalyze Value We Are Focused AVANT BIO is dedicated to fueling innovative companies in the Life Sciences and Healthtech space that are developing Therapeutic-Enabling Technologies capable of making therapies more accessible and unlocking new possibilities. Thematic Focus Equitable Access to Therapies Globally Speed and Quality in Drug Discovery New Modalities, New Needs Robust, Reliable manufacturing & Supply Chain Clinical Trial Access, Diversi
Sector and stage focus
- Series B: Consumer Health, BioTech, Health IT, Health & Hospital Services, Digital Health
- Series A: Consumer Health, Health & Hospital Services, BioTech, Digital Health, Health IT
- general: Investors who invested in diverse founders, Female Investors, Diverse Investors, Investors who were founders, Investors who invested in female founders, New York City, Canada
- Seed: Consumer Health, Health & Hospital Services, Digital Health, BioTech, Health IT
Recent investments by Daniella Kranjac
Daniella Kranjac has 4 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| Nomic | Series B | Sep 2024 | $42M |
| Envisagenics | Series A | Sep 2021 | $19M |
| RoosterBio | Series B | Sep 2019 | $7M |
| Flodesign Sonics | Series A | Jan 2018 | — |
Frequent co-investors
Daniella Kranjac has co-invested with: Zavain Dar, Peter Bordes.
Is Daniella Kranjac a fit for your round?
Upload your pitch deck and see whether Daniella Kranjac appears in your top 20 matches.
Find investors for your deck